Log In
Print
BCIQ
Print
Print this Print this
 

GMC-252

  Manage Alerts
Collapse Summary General Information
Company Genmedica Therapeutics S.L.
DescriptionDual action inhibitor of oxidative stress and inflammation
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today